2014
DOI: 10.1016/j.bjid.2013.07.011
|View full text |Cite
|
Sign up to set email alerts
|

Duplex realtime PCR method for Epstein–Barr virus and human DNA quantification: its application for post-transplant lymphoproliferative disorders detection

Abstract: The performance of the assay was suitable for the required clinical application. The assay may be useful to monitor EBV infection in transplant patients, in particular in laboratories from low-income regions that cannot afford to use commercial assays.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
13
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 42 publications
0
13
0
Order By: Relevance
“…Therefore, low-cost, POC molecular methods of EBV quantification could transform care in settings where the virus is endemic and rapid diagnosis is essential to improving BL outcomes. Particularly in areas where limited access to histopathology services can delay a definitive diagnosis of rapidly advancing BL, recent advances in POC methods to detect clonal IGH gene rearrangement and EBV viral load offer critical shorter turnaround times [75] , [76] . The tests can be applied to blood, aspirate, or biopsy samples to support a clinical diagnosis of cancer while awaiting confirmation with cytology or histology results [75] [77] .…”
Section: \Documentclass[12pt]{minimal} \Usepackage{amsmath} \Usepackamentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, low-cost, POC molecular methods of EBV quantification could transform care in settings where the virus is endemic and rapid diagnosis is essential to improving BL outcomes. Particularly in areas where limited access to histopathology services can delay a definitive diagnosis of rapidly advancing BL, recent advances in POC methods to detect clonal IGH gene rearrangement and EBV viral load offer critical shorter turnaround times [75] , [76] . The tests can be applied to blood, aspirate, or biopsy samples to support a clinical diagnosis of cancer while awaiting confirmation with cytology or histology results [75] [77] .…”
Section: \Documentclass[12pt]{minimal} \Usepackage{amsmath} \Usepackamentioning
confidence: 99%
“…Particularly in areas where limited access to histopathology services can delay a definitive diagnosis of rapidly advancing BL, recent advances in POC methods to detect clonal IGH gene rearrangement and EBV viral load offer critical shorter turnaround times [75] , [76] . The tests can be applied to blood, aspirate, or biopsy samples to support a clinical diagnosis of cancer while awaiting confirmation with cytology or histology results [75] [77] . With further development and validation, these tests have the potential to greatly improve the diagnosis and monitoring of EBV-associated cancers in resource-limited settings.…”
Section: \Documentclass[12pt]{minimal} \Usepackage{amsmath} \Usepackamentioning
confidence: 99%
“…Analyses of the in situ hybridization to assess the presence of EBV in HIV-infected patients in the saliva, was determined by PCR, whereas the amount of DNA in EBV-positive samples was estimated by titration repeated. The results showed that all patients with hairy leukoplakia EBV-DNA contained saliva [22][23][24][25].…”
Section: Saliva Testsmentioning
confidence: 94%
“…HIV-infected individuals and healthy controls showed a similar frequency of detection of viral DNA. EBV DNA was significantly amplified in the saliva of family members of HIV/EBV co-infected individuals, from here the possibilities for comparative analysis of salivary diagnostics [25,29,[35][36][37].…”
Section: Saliva Testsmentioning
confidence: 99%
“…Currently, while several protocols exist for identification of the herpesvirus genome (11), multiple PCR assays are required for the process. In recent years, real-time PCR has been increasingly applied to simplify the overall procedure and reduce performance time in detecting and quantifying virus in clinical samples (12,13). Multiplex qPCR has been suggested as an efficient alternative for simultaneous detection of HCMV, HHV-6 and HHV-7 within the same reaction (9,14).…”
Section: Introductionmentioning
confidence: 99%